生物降解高分子复合材料设计及多肽与蛋白药物控释体系

基本信息
批准号:59833140
项目类别:重点项目
资助金额:100.00
负责人:顾忠伟
学科分类:
依托单位:国家卫生健康委科学技术研究所
批准年份:1998
结题年份:2002
起止时间:1999-01-01 - 2002-12-31
项目状态: 已结题
项目参与者:杨纪元,张强,魏树礼,吕万良,李桂兰,张国栋,齐宪荣,沈赞聪,陈先丽
关键词:
生物降解复合材料多肽与蛋白药物近释体系
结项摘要

With the development of gene engineering and life science, many new.polypeptide/protein drugs are emerged for medical include family planning.application. These drugs have many merits that the traditional small molecular drugs lacks. But the polypeptide/protein drugs are unstable, that limit the wide application of these drugs. Drug delivery systems using polymer carrier/matrix is the effectual.way to improve the stability the drugs. The bioavailability can also be improved. So,many studies are focus on the preparation of Drug delivery systems for polypeptide/proteins..Many ways such as improve the preparation method, modification of polymers,synthesis of new hydrophilic monomers, etc. were investigated in this project to improve the loading rate, stability and bioavailability of the polypeptide/protein drugs.The impotent results were listed as following:1. Block copolymer of PCL/PLA was synthesized and the biodegradability in vitra and in vivo were studied. The results show that the degradation rate is slow and the copolymer can stay at least 3 years in vivo. It is suitable for long acting drugs.Based on PCL/PLA block copolymer, microspheres carried β-hCG, hepatitis vaccine,insulin were prepared by double emulsion solvent evaporation method. The stability and bioavailability of the drugs were improved.2. For improve the properties of the biodegradable copolymers of PCL/PLA series, D,L-3-methylglycolide (MG) was synthesized. By an improved method, the.yield of the MG was improved from <15% to 42%. MG copolymerized well with.PLA and PGA, and three-arm and four-arm star-shape PCL-b-PMG copolymers. The.degradation and drug releasing properties may adjust by balance the degradation rate as well as diffusion and erosion degradation process..3. For improving the hydrophilicity of the biodegradable polymers,polyethylene.glycols, glucosamine were introduced into the polyester. Hydrophilic monomers uchas 3-benzyloxymethyl-1,4-dioxane-2,5-dione (BMG) was also synthesized for this.purpose. Copolymers of PLA or PCL with BMG were prepared. The microsphere.encapsulations of polypeptides/proteins by these copolymers were prepared by double emulsion solvent evaporation method. Hydrophilicity of the polymers was found to have great influence on both the size of microspheres and the encapsulation efficiency of polypeptides/proteins. Drug loading of microspheres prepared with deprotected.copolymers was increased because of the stability of primary emulsion was improved.The stability and bioavailability of these drugs were also improved.All these results will expand the possibility of application of the polymeric polypeptide/protein drug delivery systems in medical and family planning areas.

设计全盛一类新型的能调节其亲脂性和亲水性的生物降解聚酯糖类嵌段共聚型医用高分子复合材料,并以此为载体材料研制多肽与蛋白类药物的近释体系,探讨药物释放规律的机理,提高药物的有效性和生物利用度,解决用于人口控制或疾病防治的多肽与蛋白类药物近释体系的关键性基础科学问题,从而把多肽与蛋白类药物近释体系的研究和开发推向新的阶段。.

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

硬件木马:关键问题研究进展及新动向

硬件木马:关键问题研究进展及新动向

DOI:
发表时间:2018
2

城市轨道交通车站火灾情况下客流疏散能力评价

城市轨道交通车站火灾情况下客流疏散能力评价

DOI:
发表时间:2015
3

丙二醛氧化修饰对白鲢肌原纤维蛋白结构性质的影响

丙二醛氧化修饰对白鲢肌原纤维蛋白结构性质的影响

DOI:10.7506/spkx1002-6630-20190411-143
发表时间:2020
4

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

PI3K-AKT-mTOR通路对骨肉瘤细胞顺铂耐药性的影响及其机制

DOI:
发表时间:2021
5

二维MXene材料———Ti_3C_2T_x在钠离子电池中的研究进展

二维MXene材料———Ti_3C_2T_x在钠离子电池中的研究进展

DOI:10.19964/j.issn.1006-4990.2020-0450
发表时间:2021

顾忠伟的其他基金

批准号:50633020
批准年份:2006
资助金额:140.00
项目类别:重点项目
批准号:20574047
批准年份:2005
资助金额:26.00
项目类别:面上项目
批准号:29774005
批准年份:1997
资助金额:11.00
项目类别:面上项目
批准号:51133004
批准年份:2011
资助金额:290.00
项目类别:重点项目

相似国自然基金

1

点击化学制备非线性结构生物降解高分子及其双重功能型药物控释体系

批准号:20874058
批准年份:2008
负责人:董常明
学科分类:B0507
资助金额:35.00
项目类别:面上项目
2

治疗阳痿的高分子/基因复合药物控释体系的研究

批准号:51073003
批准年份:2010
负责人:白文俊
学科分类:E0308
资助金额:38.00
项目类别:面上项目
3

细胞靶向型纳米高分子药物控释载体的设计、合成与组装

批准号:20404007
批准年份:2004
负责人:董常明
学科分类:B0507
资助金额:25.00
项目类别:青年科学基金项目
4

可生物降解高分子超细纤维药物控制释放体系

批准号:50373043
批准年份:2003
负责人:景遐斌
学科分类:E0308
资助金额:23.00
项目类别:面上项目